348 related articles for article (PubMed ID: 28759727)
21. Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.
Zheng YY; Wang M; Shu XB; Zheng PY; Ji G
World J Gastroenterol; 2018 Mar; 24(9):992-1003. PubMed ID: 29531463
[TBL] [Abstract][Full Text] [Related]
22. A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells.
Jian T; Wu Y; Ding X; Lv H; Ma L; Zuo Y; Ren B; Zhao L; Tong B; Chen J; Li W
Biomed Pharmacother; 2018 Jan; 97():1125-1130. PubMed ID: 29136950
[TBL] [Abstract][Full Text] [Related]
23. The effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture.
Moravcová A; Červinková Z; Kučera O; Mezera V; Rychtrmoc D; Lotková H
Physiol Res; 2015; 64(Suppl 5):S627-36. PubMed ID: 26674288
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
[TBL] [Abstract][Full Text] [Related]
25. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.
Siculella L; Tocci R; Rochira A; Testini M; Gnoni A; Damiano F
Biochim Biophys Acta; 2016 May; 1861(5):471-81. PubMed ID: 26869449
[TBL] [Abstract][Full Text] [Related]
26. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
Yu Q; Liu Y; Wu Y; Chen Y
Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
[TBL] [Abstract][Full Text] [Related]
27. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
28. Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.
Gori M; Simonelli MC; Giannitelli SM; Businaro L; Trombetta M; Rainer A
PLoS One; 2016; 11(7):e0159729. PubMed ID: 27438262
[TBL] [Abstract][Full Text] [Related]
29. Amelioration by
Li N; Sun YR; He LB; Huang L; Li TT; Wang TY; Tang L
Oxid Med Cell Longev; 2020; 2020():1208726. PubMed ID: 33144913
[No Abstract] [Full Text] [Related]
30. Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.
Amorim R; Simões ICM; Veloso C; Carvalho A; Simões RF; Pereira FB; Thiel T; Normann A; Morais C; Jurado AS; Wieckowski MR; Teixeira J; Oliveira PJ
Nutrients; 2021 May; 13(5):. PubMed ID: 34069635
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes.
Liang H; Zhang L; Wang H; Tang J; Yang J; Wu C; Chen S
Int J Mol Sci; 2015 Nov; 16(11):27749-56. PubMed ID: 26610473
[TBL] [Abstract][Full Text] [Related]
32. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
33. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes.
Schultz Moreira AR; Rüschenbaum S; Schefczyk S; Hendgen-Cotta U; Rassaf T; Broering R; Hardtke-Wolenski M; Buitrago-Molina LE
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167328
[TBL] [Abstract][Full Text] [Related]
34. Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.
Li Z; Zhang H; Li Y; Chen H; Wang C; Wong VKW; Jiang Z; Zhang W
Phytomedicine; 2020 Apr; 69():153209. PubMed ID: 32240928
[TBL] [Abstract][Full Text] [Related]
35. Suppression of Grb2 expression improved hepatic steatosis, oxidative stress, and apoptosis induced by palmitic acid in vitro partly through insulin signaling alteration.
Shan X; Miao Y; Fan R; Song C; Wu G; Wan Z; Zhu J; Sun G; Zha W; Mu X; Zhou G; Chen Y
In Vitro Cell Dev Biol Anim; 2013 Sep; 49(8):576-82. PubMed ID: 23771793
[TBL] [Abstract][Full Text] [Related]
36. Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis.
Rafiei H; Omidian K; Bandy B
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28317281
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells].
Zhou YP; Wu R; Shen W; Yu HH; Yu SJ
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):451-456. PubMed ID: 30317760
[No Abstract] [Full Text] [Related]
38. Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis.
Parra-Robert M; Casals E; Massana N; Zeng M; Perramón M; Fernández-Varo G; Morales-Ruiz M; Puntes V; Jiménez W; Casals G
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31470518
[TBL] [Abstract][Full Text] [Related]
39. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.
Pang L; Liu K; Liu D; Lv F; Zang Y; Xie F; Yin J; Shi Y; Wang Y; Chen D
Cell Death Dis; 2018 Jan; 9(2):90. PubMed ID: 29367738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
